Sequoia Economic Infrastructure Income Fund Limited Early Release of Placing Price

Sequoia Economic Infrastructure Income Fund Limited

Sequoia Economic Infrastructure Income Fund Limited (LON: SEQI) announced today that further to the announcement on 2 September 2019 in relation to a proposed placing of up to 125,000,000 new ordinary shares of no par value in the Company, the Board of Directors of the Company announces that the issue price of the New Shares will be 111.00 pence per New Share. At the Placing Price, assuming that 125,000,000 New Shares are issued, the gross proceeds of the Placing will be £138,750,000.

The Placing Price represents a discount of approximately 5.0 per cent. to the closing share price on 30 August 2019 of 116.80 pence, the last business day prior to the initial announcement of the Placing.

As announced earlier today, the Company’s unaudited cum-income NAV per ordinary share as at 30 August 2019 was 104.62 pence (the “NAV”). The Placing Price represents a premium of approximately 6.1 per cent. to the NAV. The Placing will be NAV accretive for existing shareholders.

The expected closing date of the Placing remains 1:00pm on 19 September 2019.

Share on:

Latest Company News

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress.

Ethtry: Ethereum Treasuries, Nation-State Partnerships and the Web3 Bet You’re Not Watching (Video)

Ethtry’s CEO Patrick Chopard reveals how the company is building a next-gen operating model by combining Ethereum-based treasuries with traditional business infrastructure—anchored by partnerships with LTIM and AMINA Bank.

    Search

    Search